Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

2.0K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

2.2K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.2K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional disparities in access to epinephrine auto-injectors for children and adults in Italy.

European annals of allergy and clinical immunology·2026
Same author

Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith Scale.

Neuromuscular disorders : NMD·2026
Same author

Allergic rhinitis management: a survey on Italian primary care pediatricians.

European annals of allergy and clinical immunology·2024
Same author

Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).

Trials·2024
Same author

Multicentric Italian case-control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome.

Journal of endocrinological investigation·2023
Same author

Factors associated with asthma exacerbations in schoolchildren: an experience in clinical practice.

European annals of allergy and clinical immunology·2022
Same journal

Identification of circRNA-mediated competing endogenous RNA network in the development of bladder urothelial carcinoma.

Journal of biological regulators and homeostatic agents·2021
Same journal

Dimethyl fumarate attenuates lipopolysaccharide-induced acute lung injury by inhibiting inflammation and oxidative stress.

Journal of biological regulators and homeostatic agents·2021
Same journal

Expression of NLR and IL-1β and their predictive efficacy value in acute myocardial infarction patients treated with aspirin combined with clopidogrel.

Journal of biological regulators and homeostatic agents·2021
Same journal

CircRNA (circ_0008057) promotes uremic serum-mediated proliferation and migration of vascular smooth muscle cells via miR-370/PLk1 signaling pathway.

Journal of biological regulators and homeostatic agents·2021
Same journal

Overexpression of miR-150-5p alleviates lipopolysaccharide-induced A549 cell injury in type II alveolar epithelial cells by inhibiting the FSTL1 signaling pathway.

Journal of biological regulators and homeostatic agents·2021
Same journal

Efficacy of early oral and perioral physiotherapy on feeding autonomy in preterm infants: results of randomized controlled trials.

Journal of biological regulators and homeostatic agents·2021
See all related articles

Related Experiment Video

Updated: Mar 29, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K

β2-AGONISTS IN CHILDHOOD ASTHMA.

M Miraglia Del Giudice1, G Campana1, F Galdo1

  • 1Department of Women, Child and General and Special Surgery, Second University of Naples, Italy.

Journal of Biological Regulators and Homeostatic Agents
|December 5, 2015
PubMed
Summary
This summary is machine-generated.

Short-acting beta-agonists (SABAs) provide quick relief for asthma symptoms, while long-acting beta-agonists (LABAs) offer sustained symptom control. This review examines recent data on these important asthma medications.

More Related Videos

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.3K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.7K

Related Experiment Videos

Last Updated: Mar 29, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K
Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.3K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.7K

Area of Science:

  • Pharmacology
  • Respiratory Medicine

Background:

  • Beta-2 agonists are bronchodilators that relax airway smooth muscle, improving airflow.
  • They are classified by duration of action: short-acting (SABAs) and long-acting (LABAs).

Purpose of the Study:

  • To review recent data on short-acting and long-acting beta-agonists.
  • To highlight the clinical applications and differences between SABAs and LABAs.

Main Methods:

  • Literature review of recent publications on beta-2 agonists.
  • Analysis of pharmacodynamic properties and clinical use of SABAs and LABAs.

Main Results:

  • SABAs (e.g., albuterol) have short half-lives (2-6h) and are used for "as needed" relief and exercise-induced bronchospasm.
  • LABAs (e.g., salmeterol, formoterol) require twice-daily dosing and provide longer symptom control, including for nocturnal symptoms.

Conclusions:

  • Beta-2 agonists are essential for managing airflow limitation in respiratory conditions.
  • LABAs offer significant advantages for sustained symptom control compared to SABAs.